Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Inconsistency Between Contrast-Enhanced CT and Bone Scintigraphy in Revealing Radiation Nephritis.

Zhu W, Zhen H, Ding N, Jing H, Huo L.

Clin Nucl Med. 2019 Jun;44(6):504-506. doi: 10.1097/RLU.0000000000002579.

PMID:
31021909
2.

Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.

Kim SJ, Choi JY, Lee JH, Hyun SH, Cho YS, Moon SH, Choe YS, Lee KH, Kim BT.

Nuklearmedizin. 2016 Aug 5;55(4):166-71. doi: 10.3413/Nukmed-0768-15-09. Epub 2015 Dec 3.

PMID:
26632485
3.

(18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.

Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G.

Hell J Nucl Med. 2011 Sep-Dec;14(3):311-2.

PMID:
22087457
4.

Tc-99m MDP, thallium-201 chloride and Tc-99m MAG3 renal uptake in subacute and chronic radiation nephritis compared.

Degirmenci B, Uysal K, Bekis R, Cetingoz R, Kaya GC, Durak H.

Ann Nucl Med. 2001 Oct;15(5):447-9.

PMID:
11758952
5.

Super Scan Caused by Parathyroid Carcinoma Observed Both in18F-FDG PET/CT Scan and Tc-99m MDP Bone Scintigraphy.

Güney İB, Paydaş S, Ballı HT.

Mol Imaging Radionucl Ther. 2017 Oct 3;26(3):116-119. doi: 10.4274/mirt.70188.

6.

Back Pain in Children and Diagnostic Value of (99m)Tc MDP Bone Scintigraphy.

Alkhawaldeh K, Ghuweri AA, Kawar J, Jaafreh A.

Acta Inform Med. 2014 Oct;22(5):297-301. doi: 10.5455/aim.2014.22.297-301. Epub 2014 Oct 29.

7.

Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.

Chakraborty D, Bhattacharya A, Mete UK, Mittal BR.

Clin Nucl Med. 2013 Aug;38(8):616-21. doi: 10.1097/RLU.0b013e31828da5cc.

PMID:
23603596
8.

Focal Increased Tc-99m MDP Uptake in the Nutrient Foramen of the Femoral Diaphysis on Bone SPECT/CT.

Cha H, Park SB, Kim HJ.

Nucl Med Mol Imaging. 2018 Apr;52(2):162-165. doi: 10.1007/s13139-017-0489-2. Epub 2017 Aug 11.

9.

More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.

Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

PMID:
30843003
10.

Sickle cell diseases: What can nuclear medicine offer?

Niccoli Asabella A, Altini C, Nappi AG, Lavelli V, Ferrari C, Marzullo A, Loiodice A, Rubini G.

Hell J Nucl Med. 2019 Jan-Apr;22(1):2-3. doi: 10.1967/s002449910950. Epub 2019 Mar 7.

PMID:
30843001
11.

Diffuse Hepatic and Spleen Uptake of Tc-99m MDP on Bone Scintigraphy Resembling Liver-Spleen Scintigraphy in a Patient of Plasma Cell Tumor.

Ravanbod MR, Nemati R, Javadi H, Nabipour I, Assadi M.

Case Rep Radiol. 2014;2014:264904. doi: 10.1155/2014/264904. Epub 2014 Mar 25.

12.

Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.

Ak I, Sivrikoz MC, Entok E, Vardareli E.

Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16.

PMID:
20015657
13.

Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.

Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, Cheow HK, Shaw AS, Bird N, Fife K, Heard S, Lomas DJ, Matakidou A, Soloviev D, Eisen T, Gallagher FA.

Ann Oncol. 2015 Oct;26(10):2113-8. doi: 10.1093/annonc/mdv289. Epub 2015 Jul 22.

14.

The role of 18F-NaF PET/CT in metastatic bone disease.

Araz M, Aras G, Küçük ÖN.

J Bone Oncol. 2015 Sep 16;4(3):92-7. doi: 10.1016/j.jbo.2015.08.002. eCollection 2015 Sep.

15.
16.

Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.

Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26601. Epub 2017 Apr 27.

PMID:
28449267
17.

Dural metastasis demonstrated on Tc-99m MDP bone scintigraphy in staging workup for a patient with breast cancer.

Truong MX, Ting AC, Rossleigh MA, Carroll SL.

Clin Nucl Med. 2006 Apr;31(4):223-4.

PMID:
16550022
18.

Evaluation of Response to Therapy in a Patient with Lung Cancer: Correlation of Sclerotic Bone Lesions with F 18 FDG PET/CT and Bone Scintigraphy.

Ozülker T, Ozülker F, Küçüköz Uzun A, Tatoğlu T, Ozpaçacı T.

Mol Imaging Radionucl Ther. 2011 Apr;20(1):29-33. doi: 10.4274/MIRT.20.06. Epub 2011 Apr 1.

19.

Diffuse increased renal uptake on bone scintigraphy in acute tubular necrosis.

Watanabe N, Shimizu M, Kageyama M, Kamei T, Seto H, Kakishita M.

Clin Nucl Med. 1994 Jan;19(1):19-21.

PMID:
8137577
20.

Utility of 99mTc-Sestamibi SPECT/CT in the Early Localization of Metastatic Parathyroid Carcinoma.

Fernando PEA, Bautista PA.

Asia Ocean J Nucl Med Biol. 2018 Spring;6(2):171-178. doi: 10.22038/aojnmb.2017.27484.1190.

Supplemental Content

Support Center